 "Divi's Lab shares surge 7% as Q1 net rises")
Shares of drug firm Divi's Laboratories on Tuesday surged nearly 7 per cent after the company posted a rise of 23 per cent rise in net profit for the first quarter ended June 30.
The scrip rose 6.58 per cent to Rs 1,268.65, its 52-week high, on BSE.
At NSE, shares of the company jumped 6.44 per cent to touch its one-year high of Rs 1,271.
Divi's Laboratories on Friday posted a rise of 23 per cent rise in net profit at Rs 301.81 crore for the first quarter.
It had posted a net profit of Rs 245.18 crore for the same period last financial year.
Net sales rose to Rs 1,005.97 crore for the first quarter compared with Rs 806.91 crore during the same period of previous financial year, Divi's had said in a regulatory filing.
The company manufactures active pharmaceutical ingredients (APIs) and intermediates.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%